Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients

Fertility and Sterility

Volumn 89, Issue 6, 2008, Pages 1670-1676

  Elgindy, Eman A ^a   El Haieg, Dahlia O ^a   El Sebaey, Azza ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Anti mullerian hormone; antral follicle count; ovarian reserve; poor response

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; OVARY; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; ULTRASOUND;

ADULT; ANTI-MULLERIAN HORMONE; COHORT STUDIES; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; HUMANS; INFERTILITY, FEMALE; LUTEAL PHASE; LUTEINIZING HORMONE; MENSTRUAL CYCLE; OOCYTE RETRIEVAL; OVARIAN FOLLICLE; OVARY; OVULATION; OVULATION INDUCTION; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 44349084687     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.05.040     Document Type: Article

References (25)

1. Josso N., Racine C., di Clemente N., Rey R., and Xavier F. The role of anti-mullerian hormone in gonadal development. Mol Cell Endocrinol 145 (1998) 3-7
2. Fanchin R., Schonauer L.M., Righini C., Guibourdenche J., Frydman R., and Taieb J. Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18 (2003) 323-327
3. Feyereisen E., Mendez Lozano D.H., Taieb J., Hesters L., Frydman R., and Fanchin R. Anti-Mullerian hormone: clinical insights into a promising biomarker of ovarian follicular status. Reprod Biomed Online 1 (2006) 695-703
4. Loverro G., Nappi L., Mei L., Giacomoantonio L., Carriero C., and Tartagni M. Evaluation of functional ovarian reserve in 60 patients. Reprod Biomed Online 7 (2003) 200-204
5. Noci I., Maggi M., Fuzzi B., Biagiotti R., Ricci F., and Marchionni M. Effect of low day 3 LH levels on in vitro fertilization treatment outcome. Gynecol Endocrinol 14 (2000) 321-326
6. Jurema M.W., Bracero N.J., and Garcia J.E. Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles. Fertil Steril 80 (2003) 1156-1161
7. Klein N.A., Battaglia D.E., Fujimoto V.Y., Davis G.S., Bremner W.J., and Soules M.R. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab 81 (1996) 1038-1045
8. Bancsi L.F., Muijs A.M., den Ouden C.T., Broekmans F.J., Looman C.W., Blankenstein M.A., et al. Basal follicle stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization. Fertil Steril 73 (2000) 552-557
9. Chang M.Y., Chiang C.H., Hsieh T.T., Soong Y.K., and Hsu K.H. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 69 (1998) 505-510
10. Bancsi L., Brockmans F., Eijkemans M., de Jong F., Habbema D., and te Velde E. Predictors in poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 77 (2002) 328-336
11. Muttukrishna S., Suharjono H., McGarrigle H., and Sathanandan M. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?. Br J Obstet Gynecol 111 (2004) 1248-1253
12. Seifer D.B., Maclaughlin D.T., Christian B.A., Feng B., and Shelden R.M. Early follicular serum mullerian inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77 (2002) 468-471
13. Sharara F.I., and McClamrock H.D. The effect of aging on ovarian volume measurements in infertile women. Obstet Gynecol 94 (1999) 57-60
14. Palermo G., Cohen J., Alikani M., Adler A., and Rasenwaks Z. Intracytoplasmic sperm injection: a novel treatment for all forms of male factor infertility. Fertil Steril 63 (1995) 1231-1240
15. Harrel F.E., Lee K.I., and Mark D.B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15 (1996) 361-387
16. Faddy M., and Gosden R.G. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 11 (1996) 1484-1486
17. Durlinger A.L., Kramer P., Karels B., de long E.H., Uilenbroek J.T., Groolegoed A., et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140 (1999) 5789-5796
18. Gougeon A. Caracteres qualitatifs et quantitatifs de la population folliculaire dons l'ovaire humain adulte. Contracept Fertil Sex 12 (1984) 527-535
19. Cook C.L., Siow Y., Taylor S., and Fallat M.E. Serum mullerian inhibiting substance levels during normal menstrual cycles. Fertil Steril 73 (2000) 859-861
20. de Vet A., Laven J.S., de Jong F.H., Themmen A.P.N., and Fauser B.C. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77 (2002) 357-362
21. Van Rooij I.A.J., Brockmans F.J.M., Velde E.R., Fauser B.C., Bancsi L.F., and Jong F.H. Serum anti-mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17 (2002) 3065-3071
22. Hendriks D.J., Mol B.W., Bancsi L.F., Te Velte E.R., and Broekmans F.J. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 83 (2005) 291-301
23. Rajpert-De Meyts E., Jorgensen N., Graem N., Muller J., Cate R.L., and Skakkebaek N.E. Expression of anti-mullerian hormone during normal and pathological gonadal development: association with differentiation of sertoli and granulosa cells. J Clin Endocrinol Metab 84 (1999) 3836-3844
24. Eldar-Geva T., Ben-Chetrit A., Spitz I.M., Rabinwitz B., Markowitz E., Mimoni T., et al. Dynamic assays of inhibin B, anti-mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 20 (2005) 3178-3183
25. Hazout A., Bouchard P., Seifer D.B., Aussage P., Junca A.M., and Cohen-Bacrie P. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 82 (2004) 1323-1329